Open AccessUse of Cerebrolysin in combination with high‐dose aspirin antithrombotic treatment of ischemic stroke: A case report
Author(s) -
Borisevich Alexander,
Veremeyuk Konstantin
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4863
Subject(s) - cerebrolysin , medicine , aspirin , neuroprotection , anesthesia , stroke (engine) , antithrombotic , ischemic stroke , regimen , cerebral edema , edema , ischemia , cardiology , mechanical engineering , engineering
This clinical case is an example of a potential synergistic neuroprotective interaction of Cerebrolysin and high doses of aspirin. The case describes the significant recovery of neurological deficits in a patient with moderate ischemic stroke (NIHSS 12 points) caused by right posterior cerebral artery thrombosis (RPCAT) after treatment with Cerebrolysin in combination with high dose of aspirin. Within 7 days after the initiation of the treatment regimen, the NIHSS score improved to 3 points and a control MRI that was performed on the 10th day after stroke, showed a significant decrease of the ischemic area and cerebral edema zone. It further might have an evidence that the combination of Cerebrolysin with high‐dose aspirin is safe and might have a synergistic effect in the treatment of ischemic stroke.